ArticlePloS one2025
Chemometrics-aided surface-enhanced Raman spectrometric detection and quantification of GH and TE hormones in blood.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Growth hormone (GH) and testosterone (TE) levels in blood are crucial indicators of human health and performance in clean sports. Deviations from normal levels can signal serious health issues, such as fertility problems, cancer, or pituitary tumors. Existing detection methods for these hormones are often costly, time-consuming, and lack portability. In this study, we explored the potential of Surface-Enhanced Raman Spectroscopy (SERS) in distinguishing blood samples from Sprague Dawley (SD) rats injected with exogenous GH, TE and both hormones from those not injected. Then, used artificial neural network (ANN) models trained, and validated in predicting levels of these hormones in blood. Blood samples from SD rats injected with GH, TE, both hormones, and non-injected rats were analyzed using the SERS method upon 785 nm laser excitation. The recorded Raman spectra from blood of GH and TE injected and non-injected rats displayed hormone-specific band intensity variations. Additionally, Principal Component Analysis (PCA) showed temporal changes in band intensities post-injection, suggesting hormone-induced biochemical alterations. In particular, Raman bands centered around 1378 cm⁻¹ for all groups, 658 cm⁻¹ for GH, and 798 cm⁻¹ for GH and TE displayed significant intensity variations. The ANN models, trained using PCA scores from blood samples with varied hormone concentrations, achieved high predictive accuracy with coefficients of determination (R² > 87.71%) and low root mean square error (RMSE < 0.6436). Elevated hormone levels were initially observed in injected rats, gradually declining over time, with results aligning closely to those obtained via ELISA kits. This work showed that the SERS method can provide rapid (~2 minutes), hormone-independent detection with minimal sample preparation. This approach demonstrated the SERS method's potential for rapid, reliable hormone detection and with customized calibration may be applied in sports doping control, clinical diagnostics, and broader biomedical research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.